Ilovetech,
Yes, by 2014 big pharma well understood the threat of DCVax from their own research indicating that it made their treatments more effective. That meant that if L passed muster on its own NWBO could be in the driver’s seat. Well that day has come and NWBO survived the attacks in the interim.
Now the effort is being made to get shareholders separated from their shares while still well undervalued between now and some time after an initial approval. Big pharma will likely try to use this time try and buy cheap but there will be competition for how to move forward and collusion to divide the spoils would likely fall apart quickly as not all pharmas are “controlled” by the “enlightened ones” and their supporters.
Big supporters of NWBO currently need to be aware of this as do retail investors who will be the target and may even be led to believe that a long time vocal supporter is really on their side when they try to use influence to move in a direction different than that of what may be best for the long term vision for extracting value from this platform. Short term vs long term financial goals is always up for debate so shareholders will likely be put to the test at some point in the fairly early stages of post approval development. Seems like the first indications of this have already been publicly shared. Best wishes.
Market Data 
Markets 
AI
